- Home
- SBGI vs OLMA Comparison
SBGI vs OLMA Comparison
Compare SBGI & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBGI
- OLMA
- Stock Information
- Founded
- SBGI 1986
- OLMA 2006
- Country
- SBGI United States
- OLMA United States
- Employees
- SBGI N/A
- OLMA N/A
- Industry
- SBGI Broadcasting
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- SBGI Industrials
- OLMA Health Care
- Exchange
- SBGI Nasdaq
- OLMA Nasdaq
- Market Cap
- SBGI 886.6M
- OLMA 725.5M
- IPO Year
- SBGI 1995
- OLMA 2020
- Fundamental
- Price
- SBGI $15.92
- OLMA $25.64
- Analyst Decision
- SBGI Buy
- OLMA Strong Buy
- Analyst Count
- SBGI 5
- OLMA 6
- Target Price
- SBGI $21.00
- OLMA $30.00
- AVG Volume (30 Days)
- SBGI 595.5K
- OLMA 7.3M
- Earning Date
- SBGI 11-05-2025
- OLMA 11-10-2025
- Dividend Yield
- SBGI 6.34%
- OLMA N/A
- EPS Growth
- SBGI N/A
- OLMA N/A
- EPS
- SBGI N/A
- OLMA N/A
- Revenue
- SBGI $3,337,000,000.00
- OLMA N/A
- Revenue This Year
- SBGI N/A
- OLMA N/A
- Revenue Next Year
- SBGI $9.50
- OLMA N/A
- P/E Ratio
- SBGI N/A
- OLMA N/A
- Revenue Growth
- SBGI N/A
- OLMA N/A
- 52 Week Low
- SBGI $11.89
- OLMA $2.86
- 52 Week High
- SBGI $18.46
- OLMA $27.17
- Technical
- Relative Strength Index (RSI)
- SBGI 55.53
- OLMA 88.19
- Support Level
- SBGI $14.52
- OLMA $7.82
- Resistance Level
- SBGI $17.88
- OLMA $24.83
- Average True Range (ATR)
- SBGI 0.88
- OLMA 2.21
- MACD
- SBGI -0.07
- OLMA 1.89
- Stochastic Oscillator
- SBGI 40.96
- OLMA 94.32
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.